Translational Cancer Research Impact Factor, Quartile, Indexing, Ranking
Translational Cancer Research (TCR) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by AME Publishing Company. The Print-ISSN of Translational Cancer Research is 2218-676X and its abbreviation is Transl Cancer Res.
The latest Impact Factor of the Translational Cancer Research for 2026-2027 is 0.9.
The Publication fees (APC) is 1390 USD.
Translational Cancer Research Aim and Scope
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; https://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in PubMed/PubMed Central and Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer, results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards.
Translational Cancer Research Details
| Journal title | Translational Cancer Research (TCR) |
| Abbreviation | Transl Cancer Res |
| Print ISSN | 2218-676X |
| Online ISSN | 2219-6803 |
| Publisher Name | AME Publishing Company |
| Editor-in-chief | Eric Y Chuang, ScD, EMBA |
| Subject Category | Medicine |
| Access type | 🔒 Subscription |
| Status | 🟢 Active |
Translational Cancer Research Metrics and Rankings
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Translational Cancer Research
| Impact Factor | 0.9 |
| SJR | 0.247 |
| SNIP | 0.189 |
| Ranking | 17002 |
| CiteScore | 1.2 |
| H-Index | 36 |
| Quartile | Q3 |
Translational Cancer Research Abstracting and Indexing
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
| Abstracting and Indexing |
Translational Cancer Research Submission
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | 🔗 Journal Website |
